Article Text

Download PDFPDF
▼Valproate medicines - Pregnancy Prevention Programme materials available

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Medicines and Healthcare Products Regulatory Agency (MHRA) and the European Medicines Agency have issued a series of warnings related to the use of valproate medicines in pregnancy and the high risk of serious developmental disorders and congenital malformations.15 This message is being reinforced with information and support materials for patients, carers and healthcare professionals.6 The materials, which will be available online and as hard copies, are aimed at ensuring that women and girls of childbearing potential taking valproate medicines are aware …

View Full Text